284 results on '"Kang, Huafeng"'
Search Results
2. Can neoadjuvant systemic therapy provide additional benefits for T1 HER2+ breast cancer patients: a subgroup analysis based on different high-risk signatures
3. Choice of wedge resection for selected T1a/bN0M0 non-small cell lung cancer
4. Evaluation of neoadjuvant chemotherapy for clinical T1 triple-negative breast cancer
5. Superbinder based phosphoproteomic landscape revealed PRKCD_pY313 mediates the activation of Src and p38 MAPK to promote TNBC progression
6. Impact of response to neoadjuvant chemotherapy on surgical modality in patients with T1-2N0-1M0 triple-negative breast cancer
7. Low-density lipoprotein: a versatile nanoscale platform for targeted delivery
8. Integrated pan-cancer analysis and experimental verification of the roles of meiotic nuclear divisions 1 in breast cancer
9. Analysis of the Relationship Between Primary Tumor Site and Clinicopathological Characteristics and Survival Prognosis of Breast Cancer Patients Based on SEER Database
10. Is neoadjuvant chemotherapy necessary for T2N0-1M0 hormone receptor-positive/HER2-negative breast cancer patients undergoing breast-conserving surgery?
11. PIK3CA mutation-driven immune signature as a prognostic marker for evaluating the tumor immune microenvironment and therapeutic response in breast cancer
12. Prognostic value and mode selection of locoregional treatment in Stage-IV breast cancer patients
13. Construction and Validation of a Nomogram Predicting the Overall Survival Benefit of Unilateral Breast Cancer Patients Undergoing Contralateral Prophylactic Mastectomy
14. “On/off”-switchable crosslinked PTX-nanoformulation with improved precise delivery for NSCLC brain metastases and restrained adverse reaction over nab-PTX
15. BMPR1B Polymorphisms (rs1434536 and rs1970801) are Associated With Breast Cancer Susceptibility in Northwest Chinese Han Females: A Case-Control Study
16. Hypoxic BMSC-derived exosomal miR-210-3p promotes progression of triple-negative breast cancer cells via NFIX-Wnt/β-catenin signaling axis.
17. Individualized pathway activity algorithm identifies oncogenic pathways in pan-cancer analysis
18. Effect of T Stages on the Choice of Axillary Evaluation Modality in Breast Cancer Patients With 1-2 Sentinel Lymph Node Metastases
19. Associations of CXCL12 polymorphisms with clinicopathological features in breast cancer: a case-control study
20. Favorable outcome of neoadjuvant endocrine treatment than surgery‐first in female HR‐positive/HER2‐negative breast cancer patients—A NCDB analysis (2010–2016)
21. Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
22. Ubiquitin-related molecular classification and risk stratification of hepatocellular carcinoma
23. Identification of an immune-related RNA-binding protein signature to predict survival and targeted therapy responses in liver cancer
24. The Efficiency and Toxicity Of Anlotinib in Combination With Docetaxel Followed by Epirubicin and Cyclophosphamide Regimen as Neoadjuvant Treatment in IIB to IIIA Triple Negative Breast Cancer: A Single-Arm, Multicenter, Open-Label, Phase II Study
25. The Prognostic Value of the Number of Negative Lymph Nodes Combined with Positive Lymph Nodes in Esophageal Cancer Patients: A Propensity-Matched Analysis
26. Identification of novel antioxidant gene signature to predict the prognosis of patients with gastric cancer
27. GOLGA7 rs11337, a Polymorphism at the MicroRNA Binding Site, Is Associated with Glioma Prognosis
28. Glycosylation Targeting: A Paradigm Shift in Cancer Immunotherapy
29. Breast cancer is associated with coronary heart disease: a cross-sectional survey of NHANES 1999–2018
30. Downregulation of APE1 potentiates breast cancer cells to olaparib by inhibiting PARP-1 expression
31. Sinomenine reduces growth and metastasis of breast cancer cells and improves the survival of tumor-bearing mice through suppressing the SHh pathway
32. Burden, trends, and risk factors of esophageal cancer in China from 1990 to 2017: an up-to-date overview and comparison with those in Japan and South Korea
33. Epidemiological trends of tracheal, bronchus, and lung cancer at the global, regional, and national levels: a population-based study
34. Prognostic Nomograms to Predict Positive Lymph Nodes in Breast Cancer Patients after Neoadjuvant Chemotherapy: Competing Risk Models Basing on the SEER Database
35. Purine and pyrimidine metabolism regulatory gene signature predicts prognosis and immunotherapy efficiency in breast cancer
36. Prognostic Value and Mode Selection of Locoregional Treatment in Stage-IV Breast Cancer Patients
37. Dasatinib promotes paclitaxel-induced necroptosis in lung adenocarcinoma with phosphorylated caspase-8 by c-Src
38. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017
39. Comprehensive analysis of nicotinamide metabolism-related signature for predicting prognosis and immunotherapy response in breast cancer
40. Saikosaponin-D reduces cisplatin-induced nephrotoxicity by repressing ROS-mediated activation of MAPK and NF-κB signalling pathways
41. Perioperative versus Preoperative Chemotherapy with Surgery in Patients with Resectable Squamous Cell Carcinoma of Esophagus: A Phase III Randomized Trial
42. Impact of the IGFBP3 A-202C polymorphism on susceptibility and clinicopathologic features of breast cancer
43. Transcriptome Features of Glycogenes Correlate with Prognosis, Tumor Microenvironment, and Treatment Response in Kidney Renal Clear Cell Carcinoma
44. Prognostic effect of radiotherapy in breast cancer patients underwent immediate reconstruction after mastectomy
45. The relationship between immediate postmastectomy reconstruction modalities and survival benefits in patients with triple negative breast cancer
46. Identification of glycogene signature as a tool to predict the clinical outcome and immunotherapy response in breast cancer
47. Membrane proteomic analysis comparing squamous cell lung cancer tissue and tumour-adjacent normal tissue
48. Global Burden of Female Breast Cancer: Age-Period-Cohort Analysis of Incidence Trends From 1990 to 2019 and Forecasts for 2035
49. Overexpression of FAM234B Predicts Poor Prognosis in Patients with Luminal Breast Cancer
50. Nomogram Predicts the Role of Primary Tumor Surgery on De Novo Stage-IV Breast Cancer Patients: A SEER-Based Competing Risk Analysis Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.